Flagship Pioneering Archives • BioTech Health X

Flagship Pioneering

1 post

Flagship Pioneering is a life sciences venture capital firm based in Cambridge, Massachusetts that invests in biotechnology, health and sustainability firms.

Portfolio companies in the Human Health vertical include:

Axcella Therapeutics

Cellarity

Codiak Biosciences

Cygnal Therapeutics

Denali Therapeutics

Evelo Biosciences

Foghorn Therapeutics

Generate Biomedicines

Incredible Foods

Inzen Therapeutics

Kaleido Biosciences

KSQ Therapeutics

Laronde

Moderna

Omega Therapeutics

Repertoire Immune Medicines

Ring Therapeutics

Rubius Therapeutics

Sana Biotechnology

Senda Biosciences

Seres Therapeutics

Sigilon Therapeutics

Syros Pharmaceuticals

Tessera Therapeutics

Valo

Cellarity-Expands-Leadership-Team-to-Continue-Evolution-of-Breakthrough-Platform-to-Encode-Biology-and-Purposefully-Create-New-DrugsCellarity-Expands-Leadership-Team

Biotech NewsCellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs

BioTech Health X
February 10, 2022

With the appointments of these experts, the firm has added to its industry knowledge, including Chief Scientific Officer…

Flagship Pioneering

Biotech NewsCellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs

Praxis (PRAX) Plunges 37% After Tremor Drug Ulixacaltamide Trial Stopped for Futility

Jazz Pharma (JAZZ) Reports $905M R&D Charge, $505M Net Loss in Q2 2025

Harrow Health (HROW) Gains Momentum With $59 Cap on Out-of-Pocket Costs

uniQure (QURE) Skyrockets 248% on Huntington’s Data

Immuneering (IMRX) Reports 86% 9-Month Survival in Pancreatic Cancer

Qualigen Therapeutics (QLGN) Secures $41M Faraday Future Deal

BriaCell (BCTX) Raises $13.8M to Advance Cancer Immunotherapy Pipeline

PepGen (PEPG) Soars 96.8% After Breakthrough DM1 Results

Hello, I’m
BioTech Health X

Subscribe toOur Updates

Subscribe to
Our Updates